Financials
Income statement
Fiscal date | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
---|---|---|---|---|
Total reported revenue | 7.8B | 6.7B | 7.0B | 7.0B |
Cost of revenue | 7.1B | 6.2B | 6.4B | 6.3B |
Gross profit | 681M | 576M | 606M | 663M |
Operating expense | ||||
Research & development | 7M | 7M | 8M | 10M |
Selling general and admin | 274M | 256M | 305M | 270M |
Other operating expenses | — | — | — | — |
Operating income | 383M | 298M | 280M | 370M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 37M | 38M | 41M |
Other income expense | -56M | -77M | -103M | -76M |
Pretax income | 290M | 184M | 139M | 253M |
Tax provision | 68M | 67M | 39M | 115M |
Net income | 222M | 117M | 100M | 138M |
Basic EPS | 2.1 | 1.1 | 0.9 | 1.2 |
Diluted EPS | 2.0 | 1.1 | 0.9 | 1.2 |
Basic average shares | 108M | 110M | 112.7M | 115.1M |
Diluted average shares | 109.3M | 111.1M | 114M | 116.7M |
EBITDA | 658M | 465M | 442M | 485M |
Net income from continuing op. | 222M | 117M | 100M | 138M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | — | — | — | — |